| Autor: |
Gopi, Anup, Iyer, Satish, Choube, Amolika |
| Předmět: |
|
| Zdroj: |
Journal of Dentistry Defense Section; Jan-Jun2022, Vol. 16 Issue 1, p66-71, 6p |
| Abstrakt: |
The treatment protocol for COVID-19 along with the presence of important confounders like diabetes and immunocompromised states may predispose individuals to COVID-19-associated mucormycosis. Since mucormycosis is a rapidly progressive and invasive infection with intracranial complications, early diagnosis followed by aggressive medical and surgical interventions is imperative to reduce the morbidity and mortality associated with the disease. The role of dental practitioners in early recognition and referral of the patient is thus paramount. A systematic investigation on the PubMed Database was undertaken and available data were compiled. This paper presents a review of mucormycosis in the current COVID-19 scenario, to act as a ready reference for dental practitioners. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
